# Oral Vitamin D Treatment for the Prevention of Hepatocellular Carcinoma

> **NCT02779465** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Third Affiliated Hospital, Sun Yat-Sen University** · enrollment: 1500 (estimated)

## Conditions studied

- Hepatitis B
- Carcinoma, Hepatocellular

## Interventions

- **DRUG:** Vitamin D3

## Key facts

- **NCT ID:** NCT02779465
- **Lead sponsor:** Third Affiliated Hospital, Sun Yat-Sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2016-06
- **Primary completion:** 2016-06
- **Final completion:** 2026-12
- **Target enrollment:** 1500 (ESTIMATED)
- **Last updated:** 2016-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02779465

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02779465, "Oral Vitamin D Treatment for the Prevention of Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02779465. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*